Go Pro
NYSE:EVH

Evolent Health Q2 2026 Earnings Report

Evolent Health logo
$5.58 +0.10 (+1.81%)
Closing price 07/8/2026 03:59 PM Eastern
Extended Trading
$5.60 +0.02 (+0.29%)
As of 07/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Evolent Health EPS Results

Actual EPS
N/A
Consensus EPS
-$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Evolent Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$597.46 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Evolent Health Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

Evolent Health Earnings Headlines

Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Agentic AI Powers U.S. Healthcare Stocks
See More Evolent Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Evolent Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evolent Health and other key companies, straight to your email.

About Evolent Health

Evolent Health (NYSE:EVH). is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise.

The company’s core offerings include care management solutions, population health analytics and clinical advisory services. Evolent Health’s technology platform integrates claims and clinical data to support risk stratification, predictive modeling and performance reporting. Through its Care Management and Evolent Clinical services, the company deploys teams of nurses, care managers and data analysts to work directly with participating providers and patients, focusing on chronic disease management, preventive care outreach and utilization management.

Evolent Health serves a broad range of geographies across the United States, with key clients spanning commercial, Medicare Advantage and Medicaid populations. The company has collaborated with regional health systems and national insurers to launch accountable care organizations (ACOs), bundled payment programs and total cost-of-care arrangements. By aligning incentives and sharing financial risk, Evolent Health’s partnerships aim to improve patient outcomes while controlling healthcare spending.

Leadership at Evolent Health is headed by Chief Executive Officer Frank Williams, who brings extensive experience in healthcare finance and operations. The management team includes industry veterans in clinical services, technology development and regulatory affairs, reflecting the company’s integrated approach to supporting its clients’ value-based care initiatives.

View Evolent Health Profile